# A Clinical Trial Using Tirzepatide to Help Adults With Type 1 Diabetes Automatically Control Their Blood Sugar

> **NCT07284511** · PHASE2,PHASE3 · NOT_YET_RECRUITING · sponsor: **Melissa-Rosina Pasqua** · enrollment: 105 (estimated)

## Conditions studied

- Type 1 Diabetes
- Type 1 Diabetes Mellitus
- T1D
- T1DM
- T1DM - Type 1 Diabetes Mellitus

## Interventions

- **DRUG:** Tirzepatide
- **DEVICE:** Tandem Control-IQ Automated Insulin Delivery System (with Dexcom G7 CGM)
- **BEHAVIORAL:** Carbohydrate Counting
- **BEHAVIORAL:** No Meal Announcement

## Key facts

- **NCT ID:** NCT07284511
- **Lead sponsor:** Melissa-Rosina Pasqua
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-01-05
- **Primary completion:** 2028-01
- **Final completion:** 2029-01
- **Target enrollment:** 105 (ESTIMATED)
- **Last updated:** 2025-12-16

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07284511

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07284511, "A Clinical Trial Using Tirzepatide to Help Adults With Type 1 Diabetes Automatically Control Their Blood Sugar". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07284511. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*